Benefit From Alkylating-Agent Chemotherapy in Oligodendrogliomas Associated With IDH Mutation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH
J. Clin. Oncol 2014 Feb 10;[EPub Ahead of Print], JG Cairncross, M Wang, RB Jenkins, EG Shaw, C Giannini, DG Brachman, JC Buckner, KL Fink, L Souhami, NJ Laperriere, JT Huse, MP Mehta, WJ CurranFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.